New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 30, 2014
08:16 EDTAUXLAuxilium revenue outlook cut removes overhang, says Leerink
Leerink believes Auxilium's revenue outlook reduction is not surprising since Testim prescriptions have been declining 26% annually and 16% compared to last quarter. The firm says the news removes an overhang on the stock and points out that Testim represents only $1 of its $36 price target for shares. Leerink keeps an Outperform rating on Auxilium.
News For AUXL From The Last 14 Days
Check below for free stories on AUXL the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for AUXL

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use